secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001140361-25-000296
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics raises $10M in registered direct offering of ~39.7M shares and warrants
--------------------------------------------------------------------------------

- Aggregate gross proceeds of ~$10M from sale of 22.9M common shares and 16.78M pre-funded warrants at $0.252/unit.
- Each share/pre-funded warrant includes a purchase warrant exercisable at $0.252; warrants require stockholder approval, expire in 5 years.
- Closing expected on January 6, 2025; H.C. Wainwright serves as placement agent with 6% cash fee.
- Net proceeds to be used for working capital, R&D, debt repayment or redemption, and capital expenditures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036125000296/0001140361-25-000296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036125000296/ny20041129x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-000296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer